Reporting on Adverse Clinical Events, 2018

DOI: 10.1177/0069477018762084

Keywords: Amiodarone (54),Angiotensin-Converting Enzyme Inhibitors (45),Angiotensin II Receptor Blockers (45),Antipyretics (51),Aripiprazole (55),Carvedilol (52),Ceftaroline (48),Chocolate (47),Cocaine (58),Fentanyl (58),Fimasartan (57),Fluoxetine (54),Lenalidomide (49),Lisinopril (52),Loperamide (50),Obeticholic Acid (46),Opioid Cessation Products (53),Rasburicase (44),Tramadol (56)

Full-Text